Kintz Samuel sold ELVN
August 19, 2025 · Form 4 insider transaction
Kintz Samuel sold 590 shares of Enliven Therapeutics, Inc. at $20.00 per share, a transaction worth $11.8K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
590
Price
$20.00
Total value
$11.8K
InsiderKintz Samuel
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateAugust 19, 2025
Filing dateAugust 20, 2025
Shares owned after929,409
OwnershipIndirect
10b5-1 planYes
AmendedNo
Footnotes
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on November 15, 2024.; The shares are held of record by The Kintz & Egan Trust Dated March 30, 2019 for which the reporting person serves as trustee.